Altimmune, Inc. SEC filings ALT

Altimmune, Inc. has 1,005 filings in SEC EDGAR's recent list, going back to Jan 31, 2011. Its latest annual report, Form ARS, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (new debt). The company's fiscal year ends on December 31.

Altimmune, Inc. SEC filings
Form Description Filed Period
8-K Current report
New debt
Oct 29, 2026 Oct 27, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 27, 2026 Oct 23, 2026
8-K Current report
Officer or director change
Sep 29, 2026 Sep 24, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 28, 2026 Jul 28, 2026
8-K Current report
Other events
Jun 16, 2026 Jun 16, 2026
S-8 Employee stock plan registration May 13, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
8-K Current report
Material agreement
Apr 24, 2026 Apr 22, 2026
424B5 Prospectus supplement Apr 24, 2026 —
S-3MEF Filing Apr 22, 2026 —
424B5 Prospectus supplement Apr 22, 2026 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Apr 16, 2026 Apr 16, 2026
ARS Annual report to shareholders Mar 17, 2026 Dec 31, 2025
DEF 14A Proxy statement Mar 17, 2026 Apr 16, 2026
PRE 14A Preliminary proxy statement Mar 6, 2026 Apr 16, 2026
10-K Annual report Mar 6, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 5, 2026 Mar 5, 2026
S-8 Employee stock plan registration Feb 6, 2026 —
8-K Current report
Other events
Feb 3, 2026 Feb 2, 2026
8-K Current report
Material agreement
Jan 28, 2026 Jan 27, 2026
424B5 Prospectus supplement Jan 28, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Dec 19, 2025 Dec 19, 2025
EFFECT Filing Dec 5, 2025 —
CORRESP Letter to the SEC Dec 3, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 1, 2025 Nov 30, 2025
S-3/A Filing Nov 13, 2025 —
S-3 Shelf registration Nov 6, 2025 —
8-K Current report
Material agreement, Agreement ended
Nov 6, 2025 Nov 6, 2025
424B5 Prospectus supplement Nov 6, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Material agreement, Results of operations, New debt
Nov 6, 2025 Nov 6, 2025
8-K Current report
Officer or director change
Oct 3, 2025 Oct 1, 2025
8-K Current report
Shareholder vote results
Sep 25, 2025 Sep 25, 2025
UPLOAD Letter from the SEC Aug 19, 2025 —
ARS Annual report to shareholders Aug 15, 2025 Dec 31, 2024
DEF 14A Proxy statement Aug 15, 2025 Sep 25, 2025
CORRESP Letter to the SEC Aug 12, 2025 —
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
UPLOAD Letter from the SEC Aug 8, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jun 26, 2025 Jun 26, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Material agreement, Results of operations, New debt, Regulation FD disclosure
May 13, 2025 May 13, 2025
EFFECT Filing Mar 13, 2025 —
8-K Current report
Other events
Mar 13, 2025 Mar 13, 2025
CORRESP Letter to the SEC Mar 11, 2025 —
UPLOAD Letter from the SEC Mar 5, 2025 —
S-3 Shelf registration Feb 27, 2025 —
S-8 Employee stock plan registration Feb 27, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations, Officer or director change
Feb 27, 2025 Feb 24, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 25, 2025 Feb 24, 2025
8-K Current report
Other events
Dec 11, 2024 Nov 15, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 12, 2024 Nov 11, 2024
8-K Current report
Shareholder vote results
Sep 26, 2024 Sep 26, 2024
ARS Annual report to shareholders Aug 15, 2024 Dec 31, 2023
DEF 14A Proxy statement Aug 15, 2024 Sep 26, 2024
8-K Current report
Officer or director change
Aug 15, 2024 Aug 13, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 26, 2024 Jun 25, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
S-8 Employee stock plan registration Mar 27, 2024 —
10-K Annual report Mar 27, 2024 Dec 31, 2023
8-K Current report
Results of operations, Other events
Mar 27, 2024 Mar 27, 2024
8-K Current report
Regulation FD disclosure, Other events
Nov 30, 2023 Nov 30, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Shareholder vote results
Sep 28, 2023 Sep 28, 2023
ARS Annual report to shareholders Aug 16, 2023 Dec 31, 2022
DEF 14A Proxy statement Aug 16, 2023 Sep 28, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Officer or director change
Mar 27, 2023 Mar 23, 2023
8-K Current report
Regulation FD disclosure, Other events
Mar 21, 2023 Mar 21, 2023
S-3ASR Automatic shelf registration Feb 28, 2023 —
S-8 Employee stock plan registration Feb 28, 2023 —
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Regulation FD disclosure, Other events
Dec 20, 2022 Dec 20, 2022
CT ORDER Filing Nov 29, 2022 —
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
8-K Current report
Shareholder vote results
Sep 29, 2022 Sep 29, 2022
8-K Current report
Regulation FD disclosure, Other events
Sep 14, 2022 Sep 14, 2022
DEF 14A Proxy statement Aug 16, 2022 Sep 29, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
S-8 Employee stock plan registration Mar 15, 2022 —
10-K Annual report Mar 15, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 15, 2022 Mar 15, 2022
8-K Current report
Agreement ended
Dec 17, 2021 Dec 17, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 13, 2021 Dec 9, 2021
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
8-K Current report
Regulation FD disclosure, Other events
Sep 28, 2021 Sep 28, 2021
8-K Current report
Shareholder vote results
Sep 24, 2021 Sep 23, 2021
DEF 14A Proxy statement Aug 16, 2021 Sep 23, 2021
10-Q Quarterly report Aug 10, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 10, 2021 Aug 10, 2021
8-K Current report
Regulation FD disclosure, Other events
Jun 29, 2021 Jun 29, 2021
8-K Current report
Regulation FD disclosure, Other events
Jun 16, 2021 Jun 16, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 17, 2021 May 17, 2021
8-K Current report
Other events
Apr 1, 2021 Apr 1, 2021
8-K Current report
Material agreement, Regulation FD disclosure
Mar 12, 2021 Mar 9, 2021
8-K Current report
Material agreement
Feb 25, 2021 Feb 25, 2021
424B5 Prospectus supplement Feb 25, 2021 —
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Other events
Feb 25, 2021 Feb 25, 2021
EFFECT Filing Jan 11, 2021 —
CORRESP Letter to the SEC Jan 7, 2021 —
UPLOAD Letter from the SEC Jan 7, 2021 —
S-3 Shelf registration Dec 31, 2020 —
8-K Current report
Other events
Dec 23, 2020 Dec 23, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
8-K Current report
Shareholder vote results
Sep 25, 2020 Sep 24, 2020
S-8 Employee stock plan registration Aug 21, 2020 —
DEF 14A Proxy statement Aug 21, 2020 Sep 24, 2020
10-Q Quarterly report Aug 11, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 11, 2020 Aug 11, 2020
8-K/A Amended current report
Officer or director change
Jul 16, 2020 May 11, 2020
8-K Current report
Material agreement, Results of operations, Other events
Jul 16, 2020 Jul 13, 2020
424B5 Prospectus supplement Jul 15, 2020 —
424B5 Prospectus supplement Jul 13, 2020 —
8-K Current report
Regulation FD disclosure, Other events
Jul 13, 2020 Jul 13, 2020
424B5 Prospectus supplement Jun 1, 2020 —
8-K Current report
Regulation FD disclosure, Other events
Jun 1, 2020 Jun 1, 2020
8-K Current report
Results of operations
May 13, 2020 May 13, 2020
10-Q Quarterly report May 13, 2020 Mar 31, 2020
8-K Current report
Officer or director change
May 12, 2020 May 11, 2020
8-K Current report
Material agreement
Apr 8, 2020 Apr 2, 2020
8-K Current report
Material agreement
Mar 27, 2020 Mar 27, 2020
424B5 Prospectus supplement Mar 27, 2020 —
10-K Annual report Mar 27, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 27, 2020 Mar 27, 2020
8-K Current report
Results of operations
Nov 13, 2019 Nov 13, 2019
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
8-K Current report
Officer or director change, Shareholder vote results
Oct 1, 2019 Sep 26, 2019
UPLOAD Letter from the SEC Aug 22, 2019 —
DEF 14A Proxy statement Aug 22, 2019 Sep 26, 2019
8-K Current report
Material agreement
Aug 21, 2019 Aug 20, 2019
PRER14A Filing Aug 19, 2019 —
CORRESP Letter to the SEC Aug 19, 2019 —
UPLOAD Letter from the SEC Aug 16, 2019 —
S-8 Employee stock plan registration Aug 14, 2019 —
8-K Current report
Results of operations
Aug 13, 2019 Aug 13, 2019
10-Q Quarterly report Aug 13, 2019 Jun 30, 2019
PRE 14A Preliminary proxy statement Aug 9, 2019 Sep 26, 2019
8-K Current report
Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
Jul 15, 2019 Jul 12, 2019
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jul 9, 2019 Jul 8, 2019
8-K Current report
Officer or director change
Jun 21, 2019 Jun 17, 2019
8-K Current report
Officer or director change
Jun 12, 2019 Jun 10, 2019
8-K Current report
Officer or director change
Jun 7, 2019 Jun 3, 2019
8-K Current report
Results of operations
May 14, 2019 May 14, 2019
10-Q Quarterly report May 14, 2019 Mar 31, 2019
UPLOAD Letter from the SEC Apr 15, 2019 —
EFFECT Filing Apr 12, 2019 —
CORRESP Letter to the SEC Apr 11, 2019 —
CORRESP Letter to the SEC Apr 11, 2019 —
S-3 Shelf registration Apr 4, 2019 —
S-8 Employee stock plan registration Apr 4, 2019 —
8-K Current report
Results of operations
Apr 1, 2019 Apr 1, 2019
10-K Annual report Apr 1, 2019 Dec 31, 2018
8-K Current report
Officer or director change
Mar 15, 2019 Mar 14, 2019
424B2 Prospectus Mar 11, 2019 —
8-K Current report
Material agreement, Other events
Mar 11, 2019 Mar 8, 2019
8-K Current report
Results of operations, Other events
Mar 8, 2019 Mar 8, 2019
8-K Current report
Officer or director change, Other events
Dec 3, 2018 Nov 28, 2018
S-8 Employee stock plan registration Nov 30, 2018 —
8-K Current report
Other events
Nov 30, 2018 Nov 30, 2018
8-K Current report
Officer or director change
Nov 27, 2018 Nov 27, 2018
10-Q Quarterly report Nov 13, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 13, 2018 Nov 13, 2018
8-K Current report
Officer or director change
Oct 22, 2018 Oct 16, 2018
424B5 Prospectus supplement Oct 9, 2018 —
424B5 Prospectus supplement Oct 9, 2018 —
8-K Current report
Material agreement, Other events
Oct 9, 2018 Oct 8, 2018
CT ORDER Filing Oct 4, 2018 —
8-K Current report
Other events
Oct 1, 2018 Sep 28, 2018
424B4 Prospectus Oct 1, 2018 —
POS EX Filing Sep 28, 2018 —
EFFECT Filing Sep 27, 2018 —
CORRESP Letter to the SEC Sep 27, 2018 —
CORRESP Letter to the SEC Sep 27, 2018 —
S-1/A Amended registration statement Sep 26, 2018 —
8-K Current report
Material agreement, Other events
Sep 25, 2018 Sep 24, 2018
424B5 Prospectus supplement Sep 24, 2018 —
8-K Current report
Material agreement, Other events
Sep 24, 2018 Sep 24, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ALT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Morristown, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1326190
Former names
PHARMATHENE, INC (until May 3, 2017); HEALTHCARE ACQUISITION CORP (until Oct 15, 2007)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.